• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估采用破坏性抽样的研究中曲线下面积相等性的随机化检验。

Randomization tests for assessing the equality of area under curves for studies using destructive sampling.

作者信息

Bailer A J, Ruberg S J

机构信息

Department of Mathematics and Statistics, Miami University, Oxford, OH 45056, USA.

出版信息

J Appl Toxicol. 1996 Sep-Oct;16(5):391-5. doi: 10.1002/(SICI)1099-1263(199609)16:5<391::AID-JAT363>3.0.CO;2-C.

DOI:10.1002/(SICI)1099-1263(199609)16:5<391::AID-JAT363>3.0.CO;2-C
PMID:8889790
Abstract

Testing the equality of the area under a curve (AUC) for different dose groups is frequently done in pharmacokinetic research. Equality of AUCs is one indicator of bioequivalence. When the experimental unit must be sacrificed to obtain a response, AUC can be simply estimated using a linear combination of response means at various time points. The distribution of this estimator is simply obtained using standard statistical theory, and statistical hypothesis tests are easily constructed. These tests assume a normal distribution of responses at each time point (or at least large enough samples to assure that the mean response is normally distributed). The applicability of this test to cases of non-normal response distributions when small numbers of observations are sampled at each time point is questionable. Randomization tests are suggested for this problem. These tests provide a valuable alternative to this normal-theory test. Discussion of the assessment of dose proportionality is also presented.

摘要

在药代动力学研究中,经常会对不同剂量组的曲线下面积(AUC)是否相等进行检验。AUC相等是生物等效性的一个指标。当必须牺牲实验单位才能获得反应时,可以使用各个时间点反应均值的线性组合来简单估计AUC。该估计量的分布可通过标准统计理论轻松获得,并且易于构建统计假设检验。这些检验假设每个时间点的反应呈正态分布(或者至少有足够大的样本以确保平均反应呈正态分布)。当每个时间点抽取的观察值数量较少时,这种检验在非正态反应分布情况下的适用性值得怀疑。针对这个问题,建议采用随机化检验。这些检验为这种正态理论检验提供了有价值的替代方法。本文还讨论了剂量比例性的评估。

相似文献

1
Randomization tests for assessing the equality of area under curves for studies using destructive sampling.用于评估采用破坏性抽样的研究中曲线下面积相等性的随机化检验。
J Appl Toxicol. 1996 Sep-Oct;16(5):391-5. doi: 10.1002/(SICI)1099-1263(199609)16:5<391::AID-JAT363>3.0.CO;2-C.
2
Sample size calculation for the Power Model for dose proportionality studies.剂量比例研究的功效模型的样本量计算。
Pharm Stat. 2007 Jan-Mar;6(1):35-41. doi: 10.1002/pst.241.
3
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.建立一种预测性有限采样策略,用于估算接受西罗莫司或环孢素联合治疗患者的麦考酚酸浓度-时间曲线下面积。
Ther Drug Monit. 2008 Aug;30(4):445-55. doi: 10.1097/FTD.0b013e318180c986.
4
Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives.截尾AUC能有效评估半衰期长的药物的生物等效性。
Int J Clin Pharmacol Ther. 1997 Apr;35(4):142-50.
5
Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics.生物等效性试验的药代动力学分析:对临床药理学和生物药剂学中性别相关问题的启示
Clin Pharmacol Ther. 2000 Nov;68(5):510-21. doi: 10.1067/mcp.2000.111184.
6
Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.在药代动力学相互作用和生物等效性交叉试验中,基于非线性混合效应模型的试验模拟评估。
Stat Med. 2005 May 30;24(10):1509-24. doi: 10.1002/sim.2047.
7
Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study.在药代动力学、生物利用度/生物等效性研究中直接比较浓度曲线。
Stat Med. 2005 Mar 30;24(6):883-91. doi: 10.1002/sim.1977.
8
Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.低剂量奈达铂在非小细胞肺癌患者中的药代动力学及AUC预测的验证
Cancer Chemother Pharmacol. 2007 Apr;59(5):575-80. doi: 10.1007/s00280-006-0298-2. Epub 2006 Aug 16.
9
A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.在接受含环孢素A和不含环孢素A免疫抑制方案的稳定心脏移植患者中,通过有限采样策略监测霉酚酸暴露时,测量谷浓度与简化AUC估计值的比较。
Clin Ther. 2006 Jun;28(6):893-905. doi: 10.1016/j.clinthera.2006.06.015.
10
Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.评估盒式给药法在小鼠中评估格尔德霉素类似物药代动力学的应用。
Cancer Chemother Pharmacol. 2004 Dec;54(6):475-86. doi: 10.1007/s00280-004-0853-7. Epub 2004 Jul 29.

引用本文的文献

1
Profile of a Multivariate Observation under Destructive Sampling-A Monte Carlo Approach to a Case of Spina Bifida.破坏性抽样下多元观察的概况——脊柱裂病例的蒙特卡洛方法
Bioengineering (Basel). 2024 Mar 3;11(3):249. doi: 10.3390/bioengineering11030249.
2
Comparison of tenofovir plasma and tissue exposure using a population pharmacokinetic model and bootstrap: a simulation study from observed data.使用群体药代动力学模型和自抽样法比较替诺福韦的血浆和组织暴露:基于观察数据的模拟研究
J Pharmacokinet Pharmacodyn. 2017 Dec;44(6):631-640. doi: 10.1007/s10928-017-9554-9. Epub 2017 Nov 8.
3
Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.
在序贯采样设计中进行药代动力学参数的非隔室估计。
J Pharmacokinet Pharmacodyn. 2009 Oct;36(5):479-94. doi: 10.1007/s10928-009-9133-9. Epub 2009 Oct 22.
4
Establishing bioequivalence in serial sacrifice designs.在系列牺牲设计中建立生物等效性。
J Pharmacokinet Pharmacodyn. 2007 Feb;34(1):103-13. doi: 10.1007/s10928-006-9037-x. Epub 2006 Oct 12.
5
Variability of the model-independent AUC: the one sample per individual case.与模型无关的AUC的变异性:每个个体病例一个样本。
J Pharmacokinet Biopharm. 1999 Aug;27(4):437-64. doi: 10.1023/a:1020921323001.
6
Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data.根据破坏性获取的药代动力学数据估算曲线下面积的置信区间。
J Pharmacokinet Biopharm. 1998 Feb;26(1):87-102. doi: 10.1023/a:1023228925137.